Evidence map›Paper›PMID 41310234›Full record

ArticleNature microbiology2025

Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spread.

Darlan da Silva Candido, Simon Dellicour, Laura V Cooper, Carlos A Prete, David Jorgensen, Christopher B Uzzell, Arend Voorman, Hil Lyons, Dimitra Klapsa, Manasi Majumdar and 6 more

Abstract read
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Darlan da Silva CandidoMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK. ddasilva@ic.ac.uk.ORCID http://orcid.org/0000-0002-5080-3130
Simon DellicourSpatial Epidemiology Lab, Université Libre de Bruxelles, Brussels, Belgium.ORCID http://orcid.org/0000-0001-9558-1052
Laura V CooperMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Carlos A PreteMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
David JorgensenMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-4982-3764
Christopher B UzzellMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Arend VoormanGates Foundation, Seattle, WA, USA.
Hil LyonsGates Foundation, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-0325-006X
Dimitra KlapsaDivision of Vaccines, Medicines and Healthcare products Regulatory Agency, South Mimms, UK.
Manasi MajumdarDivision of Vaccines, Medicines and Healthcare products Regulatory Agency, South Mimms, UK.
Kafayat ArowoloDivision of Vaccines, Medicines and Healthcare products Regulatory Agency, South Mimms, UK.ORCID http://orcid.org/0000-0001-7972-3284
Corey M PeakGates Foundation, Seattle, WA, USA.
Ananda S BandyopadhyayGates Foundation, Seattle, WA, USA.
Javier MartinDivision of Vaccines, Medicines and Healthcare products Regulatory Agency, South Mimms, UK.
Nicholas C GrasslyMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-6067-4507
Isobel M BlakeMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-3977-1318

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV-043859EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 874850Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) F.4515.22Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G098321NGates Foundation INV-031605
6 · The paper itself

Abstract

Outbreaks of vaccine-derived poliovirus type 2 (cVDPV2) have become a major threat to polio eradication. However, variations in spatiotemporal spread have not been quantified. Here we analysed cVDPV2 cases and wild poliovirus type 1 sequences to uncover spatiotemporal patterns and drivers of poliovirus spread. Between 1 May 2016 and 29 September 2023, 3,120 cVDPV2 poliomyelitis cases were reported across 75 outbreaks in 39 countries. Outbreaks had a median observed circulation of 202 (range 0-1,905) days and a median maximum distance of 231 (range 0-4,442) km. Wavefront velocity analysis of large outbreaks revealed a median velocity of spread of 2.3 (5th-95th percentile 0.7-9.2) km per day. International borders were associated with a slower velocity of spread (P < 0.001), in periods with high estimated population immunity. Phylogeographic analysis of 1,572 global wild poliovirus 1 sequences revealed that historic spread resembles recent cVDPV2 patterns and that international spread is largely sustained by unidirectional movement between neighbouring countries. Our findings offer insights for enhancing the geographical scope of vaccination response in the final phases of poliovirus eradication.

Indexed as

PoliomyelitisPoliovirusPoliovirus Vaccine, OralPoliovirus VaccinesDisease OutbreaksGlobal HealthHumansPhylogenyPhylogeographySpatio-Temporal AnalysisVaccinationPoliovirus Vaccine, OralPoliovirus Vaccines

Identifiers

PMID41310234
PMCPMC12669034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.